Loading…

Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis

Background: In recent years, gallstones have become a major condition affecting people’s health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-10, Vol.13, p.882764-882764
Main Authors: Gao, Fan, Guan, Dongyao, Wang, Gangliang, Zhang, Luting, He, Junmin, Lv, Wenqiao, Zhang, Xiaofeng, Tao, Weifeng, Dai, YeFeng, Xu, Song, Chen, Yeqi, Lu, Bin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3
cites cdi_FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3
container_end_page 882764
container_issue
container_start_page 882764
container_title Frontiers in pharmacology
container_volume 13
creator Gao, Fan
Guan, Dongyao
Wang, Gangliang
Zhang, Luting
He, Junmin
Lv, Wenqiao
Zhang, Xiaofeng
Tao, Weifeng
Dai, YeFeng
Xu, Song
Chen, Yeqi
Lu, Bin
description Background: In recent years, gallstones have become a major condition affecting people’s health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a research focus. Cholesterol homeostasis can be regulated by the liver and intestinal tract in our bodies, and intestinal flora can regulate the digestion and absorption of cholesterol. These two factors are closely related to the formation of gallstones. Aim: To investigate the effects of tauroursodeoxycholic acid (TUDCA) and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis. Methods: For this study, 96 patients with cholecystolithiasis were recruited at our hospital. The patients were randomly divided into four groups according to a random number table: group Ⅰ (TUDCA, 24 cases), group Ⅱ (intestinal probiotics, 24 cases), group Ⅲ (TUDCA and intestinal probiotics, 24 cases) and group Ⅳ (control group, 24 cases). All patients underwent laparoscopic gallbladder-preserving lithotomy or laparoscopic cholecystectomy. Bile samples were identified and extracted during the operation. Results: The results revealed that the levels of serum total bile acid (TBA), serum total cholesterol (TCHOL) and serum triglyceride in groups I, II and III before and after the intervention were statistically significant ( p < 0.05). There were significant differences in serum low-density lipoprotein cholesterol (LDL-C) between groups I and II before and after the intervention ( p < 0.05), but the serum LDL-C level in group Ⅲ before and after the intervention was similar ( p > 0.05). Regarding bile, TBA levels demonstrated no significant difference between groups I and III ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). No significant difference was identified in phospholipid and TCHOL levels between groups I and Ⅲ ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). There were significant differences in the levels of free Ca 2+ , pH value and glycoprotein in bile among the four groups ( p < 0.05). The levels of cholic acid, chenodeoxycholic acid and deoxycholic acid in bile were significantly different among the four groups ( p < 0.05). The level of lithocholic acid (LCA) in groups Ⅱ and Ⅲ was similar, as was the level
doi_str_mv 10.3389/fphar.2022.882764
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_658b783a128846268182f300a7a7a7c6</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_658b783a128846268182f300a7a7a7c6</doaj_id><sourcerecordid>2735169283</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3</originalsourceid><addsrcrecordid>eNpVUk1v1DAQjRBIVG1_ADcfuezWsR2vc0FCVYFKlbiUszXxRzNVYgfbge6P4b_idCtE7YNHM2_e04xf03xo6Z5z1V_5ZYS0Z5SxvVLsIMWb5qyVku961bK3_8Xvm8ucH2k9vO-5FGfNnxvvnSmZRE9igokUWFNcU47WxaejGeOEhoBBSyDYq5gIhuJywVCxS4oDxoKmtgeSXVpnUhNmdDOaWsdg3ZPLW2fNT46YOC8xY8EKx0AWKOhCFf-NZSSbljPHXKpkGREy5ovmnYcpu8uX97z58eXm_vrb7u7719vrz3c7IwQrO6YsHaQSnRpYp5QHS73rFKfWDD13Cqiqu-lBgBeUGWZ9N3QMhBN9B9Zaft7cnnhthEe9JJwhHXUE1M-JmB40pDrn5LSsIgfFoWVKCcmkahXznFI4bNfIyvXpxLWsw-ysqQPWvb4ifV0JOOqH-Ev3kqv6MZXg4wtBij_Xums9YzZumiC4uGbNDrxrZc_UBm1PUJNizsn5fzIt1Zs19LM19GYNfbIG_wv287Mi</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2735169283</pqid></control><display><type>article</type><title>Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis</title><source>Open Access: PubMed Central</source><creator>Gao, Fan ; Guan, Dongyao ; Wang, Gangliang ; Zhang, Luting ; He, Junmin ; Lv, Wenqiao ; Zhang, Xiaofeng ; Tao, Weifeng ; Dai, YeFeng ; Xu, Song ; Chen, Yeqi ; Lu, Bin</creator><creatorcontrib>Gao, Fan ; Guan, Dongyao ; Wang, Gangliang ; Zhang, Luting ; He, Junmin ; Lv, Wenqiao ; Zhang, Xiaofeng ; Tao, Weifeng ; Dai, YeFeng ; Xu, Song ; Chen, Yeqi ; Lu, Bin</creatorcontrib><description><![CDATA[Background: In recent years, gallstones have become a major condition affecting people’s health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a research focus. Cholesterol homeostasis can be regulated by the liver and intestinal tract in our bodies, and intestinal flora can regulate the digestion and absorption of cholesterol. These two factors are closely related to the formation of gallstones. Aim: To investigate the effects of tauroursodeoxycholic acid (TUDCA) and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis. Methods: For this study, 96 patients with cholecystolithiasis were recruited at our hospital. The patients were randomly divided into four groups according to a random number table: group Ⅰ (TUDCA, 24 cases), group Ⅱ (intestinal probiotics, 24 cases), group Ⅲ (TUDCA and intestinal probiotics, 24 cases) and group Ⅳ (control group, 24 cases). All patients underwent laparoscopic gallbladder-preserving lithotomy or laparoscopic cholecystectomy. Bile samples were identified and extracted during the operation. Results: The results revealed that the levels of serum total bile acid (TBA), serum total cholesterol (TCHOL) and serum triglyceride in groups I, II and III before and after the intervention were statistically significant ( p < 0.05). There were significant differences in serum low-density lipoprotein cholesterol (LDL-C) between groups I and II before and after the intervention ( p < 0.05), but the serum LDL-C level in group Ⅲ before and after the intervention was similar ( p > 0.05). Regarding bile, TBA levels demonstrated no significant difference between groups I and III ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). No significant difference was identified in phospholipid and TCHOL levels between groups I and Ⅲ ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). There were significant differences in the levels of free Ca 2+ , pH value and glycoprotein in bile among the four groups ( p < 0.05). The levels of cholic acid, chenodeoxycholic acid and deoxycholic acid in bile were significantly different among the four groups ( p < 0.05). The level of lithocholic acid (LCA) in groups Ⅱ and Ⅲ was similar, as was the level of LCA in groups I and ⅠV, but the difference in level between the other two groups was statistically significant ( p < 0.05). Conclusion: The combination of TUDCA and intestinal probiotics did not enhance the effect of either treatment. The use of intestinal probiotics alone can maximise the reverse development of bile composition in patients with cholecystolithiasis compared with TUDCA alone and a combination of TUDCA and intestinal probiotics, thereby reducing gallstone formation.]]></description><identifier>ISSN: 1663-9812</identifier><identifier>EISSN: 1663-9812</identifier><identifier>DOI: 10.3389/fphar.2022.882764</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>bile composition ; cholecystolithiasis ; cholelithiasis ; intestinal probiotics ; Pharmacology ; tauroursodeoxycholic acid</subject><ispartof>Frontiers in pharmacology, 2022-10, Vol.13, p.882764-882764</ispartof><rights>Copyright © 2022 Gao, Guan, Wang, Zhang, He, Lv, Zhang, Tao, Dai, Xu, Chen and Lu. 2022 Gao, Guan, Wang, Zhang, He, Lv, Zhang, Tao, Dai, Xu, Chen and Lu</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3</citedby><cites>FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638003/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638003/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids></links><search><creatorcontrib>Gao, Fan</creatorcontrib><creatorcontrib>Guan, Dongyao</creatorcontrib><creatorcontrib>Wang, Gangliang</creatorcontrib><creatorcontrib>Zhang, Luting</creatorcontrib><creatorcontrib>He, Junmin</creatorcontrib><creatorcontrib>Lv, Wenqiao</creatorcontrib><creatorcontrib>Zhang, Xiaofeng</creatorcontrib><creatorcontrib>Tao, Weifeng</creatorcontrib><creatorcontrib>Dai, YeFeng</creatorcontrib><creatorcontrib>Xu, Song</creatorcontrib><creatorcontrib>Chen, Yeqi</creatorcontrib><creatorcontrib>Lu, Bin</creatorcontrib><title>Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis</title><title>Frontiers in pharmacology</title><description><![CDATA[Background: In recent years, gallstones have become a major condition affecting people’s health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a research focus. Cholesterol homeostasis can be regulated by the liver and intestinal tract in our bodies, and intestinal flora can regulate the digestion and absorption of cholesterol. These two factors are closely related to the formation of gallstones. Aim: To investigate the effects of tauroursodeoxycholic acid (TUDCA) and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis. Methods: For this study, 96 patients with cholecystolithiasis were recruited at our hospital. The patients were randomly divided into four groups according to a random number table: group Ⅰ (TUDCA, 24 cases), group Ⅱ (intestinal probiotics, 24 cases), group Ⅲ (TUDCA and intestinal probiotics, 24 cases) and group Ⅳ (control group, 24 cases). All patients underwent laparoscopic gallbladder-preserving lithotomy or laparoscopic cholecystectomy. Bile samples were identified and extracted during the operation. Results: The results revealed that the levels of serum total bile acid (TBA), serum total cholesterol (TCHOL) and serum triglyceride in groups I, II and III before and after the intervention were statistically significant ( p < 0.05). There were significant differences in serum low-density lipoprotein cholesterol (LDL-C) between groups I and II before and after the intervention ( p < 0.05), but the serum LDL-C level in group Ⅲ before and after the intervention was similar ( p > 0.05). Regarding bile, TBA levels demonstrated no significant difference between groups I and III ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). No significant difference was identified in phospholipid and TCHOL levels between groups I and Ⅲ ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). There were significant differences in the levels of free Ca 2+ , pH value and glycoprotein in bile among the four groups ( p < 0.05). The levels of cholic acid, chenodeoxycholic acid and deoxycholic acid in bile were significantly different among the four groups ( p < 0.05). The level of lithocholic acid (LCA) in groups Ⅱ and Ⅲ was similar, as was the level of LCA in groups I and ⅠV, but the difference in level between the other two groups was statistically significant ( p < 0.05). Conclusion: The combination of TUDCA and intestinal probiotics did not enhance the effect of either treatment. The use of intestinal probiotics alone can maximise the reverse development of bile composition in patients with cholecystolithiasis compared with TUDCA alone and a combination of TUDCA and intestinal probiotics, thereby reducing gallstone formation.]]></description><subject>bile composition</subject><subject>cholecystolithiasis</subject><subject>cholelithiasis</subject><subject>intestinal probiotics</subject><subject>Pharmacology</subject><subject>tauroursodeoxycholic acid</subject><issn>1663-9812</issn><issn>1663-9812</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVUk1v1DAQjRBIVG1_ADcfuezWsR2vc0FCVYFKlbiUszXxRzNVYgfbge6P4b_idCtE7YNHM2_e04xf03xo6Z5z1V_5ZYS0Z5SxvVLsIMWb5qyVku961bK3_8Xvm8ucH2k9vO-5FGfNnxvvnSmZRE9igokUWFNcU47WxaejGeOEhoBBSyDYq5gIhuJywVCxS4oDxoKmtgeSXVpnUhNmdDOaWsdg3ZPLW2fNT46YOC8xY8EKx0AWKOhCFf-NZSSbljPHXKpkGREy5ovmnYcpu8uX97z58eXm_vrb7u7719vrz3c7IwQrO6YsHaQSnRpYp5QHS73rFKfWDD13Cqiqu-lBgBeUGWZ9N3QMhBN9B9Zaft7cnnhthEe9JJwhHXUE1M-JmB40pDrn5LSsIgfFoWVKCcmkahXznFI4bNfIyvXpxLWsw-ysqQPWvb4ifV0JOOqH-Ev3kqv6MZXg4wtBij_Xums9YzZumiC4uGbNDrxrZc_UBm1PUJNizsn5fzIt1Zs19LM19GYNfbIG_wv287Mi</recordid><startdate>20221024</startdate><enddate>20221024</enddate><creator>Gao, Fan</creator><creator>Guan, Dongyao</creator><creator>Wang, Gangliang</creator><creator>Zhang, Luting</creator><creator>He, Junmin</creator><creator>Lv, Wenqiao</creator><creator>Zhang, Xiaofeng</creator><creator>Tao, Weifeng</creator><creator>Dai, YeFeng</creator><creator>Xu, Song</creator><creator>Chen, Yeqi</creator><creator>Lu, Bin</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20221024</creationdate><title>Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis</title><author>Gao, Fan ; Guan, Dongyao ; Wang, Gangliang ; Zhang, Luting ; He, Junmin ; Lv, Wenqiao ; Zhang, Xiaofeng ; Tao, Weifeng ; Dai, YeFeng ; Xu, Song ; Chen, Yeqi ; Lu, Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>bile composition</topic><topic>cholecystolithiasis</topic><topic>cholelithiasis</topic><topic>intestinal probiotics</topic><topic>Pharmacology</topic><topic>tauroursodeoxycholic acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gao, Fan</creatorcontrib><creatorcontrib>Guan, Dongyao</creatorcontrib><creatorcontrib>Wang, Gangliang</creatorcontrib><creatorcontrib>Zhang, Luting</creatorcontrib><creatorcontrib>He, Junmin</creatorcontrib><creatorcontrib>Lv, Wenqiao</creatorcontrib><creatorcontrib>Zhang, Xiaofeng</creatorcontrib><creatorcontrib>Tao, Weifeng</creatorcontrib><creatorcontrib>Dai, YeFeng</creatorcontrib><creatorcontrib>Xu, Song</creatorcontrib><creatorcontrib>Chen, Yeqi</creatorcontrib><creatorcontrib>Lu, Bin</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gao, Fan</au><au>Guan, Dongyao</au><au>Wang, Gangliang</au><au>Zhang, Luting</au><au>He, Junmin</au><au>Lv, Wenqiao</au><au>Zhang, Xiaofeng</au><au>Tao, Weifeng</au><au>Dai, YeFeng</au><au>Xu, Song</au><au>Chen, Yeqi</au><au>Lu, Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis</atitle><jtitle>Frontiers in pharmacology</jtitle><date>2022-10-24</date><risdate>2022</risdate><volume>13</volume><spage>882764</spage><epage>882764</epage><pages>882764-882764</pages><issn>1663-9812</issn><eissn>1663-9812</eissn><abstract><![CDATA[Background: In recent years, gallstones have become a major condition affecting people’s health. Cholecystectomy remains an effective treatment method, but it has large risk factors. It is well known that the hepatoenteric axis plays a key role in gallstone formation, and it is gradually becoming a research focus. Cholesterol homeostasis can be regulated by the liver and intestinal tract in our bodies, and intestinal flora can regulate the digestion and absorption of cholesterol. These two factors are closely related to the formation of gallstones. Aim: To investigate the effects of tauroursodeoxycholic acid (TUDCA) and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis. Methods: For this study, 96 patients with cholecystolithiasis were recruited at our hospital. The patients were randomly divided into four groups according to a random number table: group Ⅰ (TUDCA, 24 cases), group Ⅱ (intestinal probiotics, 24 cases), group Ⅲ (TUDCA and intestinal probiotics, 24 cases) and group Ⅳ (control group, 24 cases). All patients underwent laparoscopic gallbladder-preserving lithotomy or laparoscopic cholecystectomy. Bile samples were identified and extracted during the operation. Results: The results revealed that the levels of serum total bile acid (TBA), serum total cholesterol (TCHOL) and serum triglyceride in groups I, II and III before and after the intervention were statistically significant ( p < 0.05). There were significant differences in serum low-density lipoprotein cholesterol (LDL-C) between groups I and II before and after the intervention ( p < 0.05), but the serum LDL-C level in group Ⅲ before and after the intervention was similar ( p > 0.05). Regarding bile, TBA levels demonstrated no significant difference between groups I and III ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). No significant difference was identified in phospholipid and TCHOL levels between groups I and Ⅲ ( p > 0.05), and the differences between the other two groups were statistically significant ( p < 0.05). There were significant differences in the levels of free Ca 2+ , pH value and glycoprotein in bile among the four groups ( p < 0.05). The levels of cholic acid, chenodeoxycholic acid and deoxycholic acid in bile were significantly different among the four groups ( p < 0.05). The level of lithocholic acid (LCA) in groups Ⅱ and Ⅲ was similar, as was the level of LCA in groups I and ⅠV, but the difference in level between the other two groups was statistically significant ( p < 0.05). Conclusion: The combination of TUDCA and intestinal probiotics did not enhance the effect of either treatment. The use of intestinal probiotics alone can maximise the reverse development of bile composition in patients with cholecystolithiasis compared with TUDCA alone and a combination of TUDCA and intestinal probiotics, thereby reducing gallstone formation.]]></abstract><pub>Frontiers Media S.A</pub><doi>10.3389/fphar.2022.882764</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1663-9812
ispartof Frontiers in pharmacology, 2022-10, Vol.13, p.882764-882764
issn 1663-9812
1663-9812
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_658b783a128846268182f300a7a7a7c6
source Open Access: PubMed Central
subjects bile composition
cholecystolithiasis
cholelithiasis
intestinal probiotics
Pharmacology
tauroursodeoxycholic acid
title Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A28%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20oral%20tauroursodeoxycholic%20acid%20and/or%20intestinal%20probiotics%20on%20serum%20biochemical%20indexes%20and%20bile%20composition%20in%20patients%20with%20cholecystolithiasis&rft.jtitle=Frontiers%20in%20pharmacology&rft.au=Gao,%20Fan&rft.date=2022-10-24&rft.volume=13&rft.spage=882764&rft.epage=882764&rft.pages=882764-882764&rft.issn=1663-9812&rft.eissn=1663-9812&rft_id=info:doi/10.3389/fphar.2022.882764&rft_dat=%3Cproquest_doaj_%3E2735169283%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-28d0b68458b2588fad0fe5830dcb93e8a080229a4af402c2df5b52a4e495addd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2735169283&rft_id=info:pmid/&rfr_iscdi=true